What justifies a placebo-controlled trial of Varenicline for smoking cessation in patients with COPD?

Chest. 2011 Apr;139(4):968-969. doi: 10.1378/chest.10-2919.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzazepines / therapeutic use*
  • Humans
  • Nicotinic Agonists / therapeutic use
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Quinoxalines / therapeutic use*
  • Randomized Controlled Trials as Topic*
  • Smoking / adverse effects
  • Smoking Cessation / methods*
  • Smoking Prevention*
  • Treatment Outcome
  • Varenicline

Substances

  • Benzazepines
  • Nicotinic Agonists
  • Quinoxalines
  • Varenicline